FIELD: organic chemistry, medicine, immunology, pharmacy.
SUBSTANCE: invention relates to novel immune active aminoalkylglucosaminide phosphate compounds of the formula (V):
or its pharmaceutically acceptable salts wherein X is chosen from the group consisting of -O- and -NH-; R1, R2 and R3 are chosen independently of one another from the group consisting of (C9-C14)-acyl groups. Also, invention relates to the immunostimulating pharmaceutical composition comprising pharmaceutically acceptable carrier and the therapeutically effective dose of compound of the formula (V), and to a method for inducing the immune response in a patient.
EFFECT: improved inducing response method, valuable medicinal properties of compounds and pharmaceutical composition.
19 cl, 4 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
PREVENTIVE AND THERAPEUTIC METHOD FOR TREATING INFECTIOUS AND OTHER DISEASES BY APPLYING IMMUNOEFFECTIVE COMPOUNDS | 2002 |
|
RU2288723C2 |
SYNTHETIC GLUCOPYRANOSYLLIPID ADJUVANTS | 2010 |
|
RU2560182C2 |
SYNTHETIC GLUCOPYRANOSYL LIPOID ADJUVANTS | 2010 |
|
RU2732574C2 |
CERTAIN AMINOALKYL GLUCOSAMINIDE PHOSPAHTE DERIVATIVES AND USE THEREOF | 2004 |
|
RU2389732C2 |
SOME AMINO ALKYL GLUCOSE AMINIDE PHOSPHATE DERIVATIVES AND THEREOF APPLICATION | 2004 |
|
RU2544850C2 |
COMPOSITION CONTAINING TLR AGONIST AND METHODS FOR ITS APPLICATION | 2017 |
|
RU2761870C2 |
USE OF MONOMYCOLYL GLYCEROL (MMG) AS ADJUVANT | 2008 |
|
RU2479317C2 |
METHODS OF OBTAINING AMINOALKYLGLUCOSAMINIDPHOSPHATES AND DISACCHARIDE IMMUNOEFFECTORS AND THEIR INTERMEDIATE COMPOUNDS | 2003 |
|
RU2340621C2 |
FMDV VACCINES BASED ON A RECOMBINANT ADENOVIRAL VECTOR AND USE THEREOF | 2017 |
|
RU2725495C2 |
NEW ADJUVANT COMPOSITIONS | 2009 |
|
RU2510280C2 |
Authors
Dates
2006-12-20—Published
2002-02-04—Filed